LOADING...
   NP_810227.1;CL5305C
 Protein Sequence Comparative Analysis   (PSCA)
 
  Back to Target List
 
 FFAS03 results for 359105
current user: public


Query: CL5305C NP_810227.1 359105 PDB-2010-12-07, from JCSG0113

Results of FFAS03 search in PDB0113
Master-slave alignment does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .
# Score Template Links and tools%idFirst MKKNILFFYCLLVVAVVSLKAQEIRPMPADSAYGVVHISVCNMRDEGKFTSGMSTQALLGMPVKVLQYTGWYEIQTPDDYTGWVHRMVITPMSKEKYDEWNRAEKIVVTSHYGFTYEKPDDDSQTVSDVVAGNRLKWEGSKGHFYKVSYPDGRQAYISRHISQPESKWRASLKQDAESIIKTAYTMIGIPYLWAGTSSKGVDCSGLVRTVLFMHDIIIPRDASQQAYVGERIEIAPDFSNVQRGDLVFFGRKATADRKEGISHVGIYLGNKRFIHALGDVHISSFDPEDECYDEFNTGRLLFATRFLPYINKEKGMNTTDHNLYYLHHLast
1 -107.0003pvq_A mol:protein length:308 Dipeptidyl-peptidase VI  ali model follow..  99  1....................GQEIRPMPADSAYGVVHISVCNMRDEGKFTSGMSTQALLGMPVKVLQYTGWYEIQTPDDYTGWVHRMVITPMSKEKYDEWNRAEKIVVTSHYGFTYEKPDDDSQTVSDVVAGNRLKWEGSKGHFYKVSYPDGRQAYISRHISQPESKWRASLKQDAESIIKTAYTMIGIPYLWAGTSSKGVDCSGLVRTVLFMHDIIIPRDASQQAYVGERIEIAPDFSNVQRGDLVFFGRKATADRKEGISHVGIYLGNKRFIHALGDVHISSFDPEDECYDEFNTGRLLFATRFLPYINKEKGMNTTDHNLYYLHH 308
2 -104.0003npf_A mol:protein length:306 putative dipeptidyl-peptidase VI  ali model follow..  87  1....................GQEIRPMPADSAYGVVHISVCNLREEGKFTSGMSTQALLGMPVKVLQYNGWYEIQTPDDYTGWVHRMVITPMSKERYDEWNRAEKIVVTSHYGFAYEKPDESSQPVSDVVAGNRLKWEGSKGHFYQVSYPDGRKAYLSKSISQPEAGWRASLKQDVESIIETAYSMMGIPYLWAGTSSKGVDCSGLVRTVLFMHDIIIPRDASQQAYVGEHIDIAPDFSNVKRGDLVFFGRKATAERKEGISHVGIYLGNKQFIHALGDVHVSSMNPADQNYDEFNTKRLLFAVRFLPYINKEKGMNTTNKNPFYQ.. 306
3 -78.9003h41_A mol:protein length:311 NLP/P60 family protein  ali model follow..  24  29.....................DVPSATNPVDLWKWTKSMTLDEKLWLTNANKLETQALLGQEVTVVDKKGWVKVLNEEGYPGWMPEKQLTYNQEFA--DKTNEPFVLVTKPTAILYINPSEKHKSL-EVSYNTRLPLLSEDTISYRVLLPNGQKAWLRKNDGTFYRSQNDIPTPAADDLINTGKMFLGLPYIWAGTSGFGFDCSGFTHTIYKSHGITIPRDSGPQSRNGVAVD----KEHLQKGDLIFFAH---DQGKGSVHHVAMYIGDGNMIHSPRAERSVEIIPLN---TPGYIEEYAGARRYLP.................... 311
4 -63.2002hbw_A mol:protein length:235 NLP/P60 protein  ali model follow..  23  2..................MLSNLESSIQSPKSGEYQCLAALNLYDSPECTS-LATQAAVGRHLQVTSNGAAVEVCLEDDYPGWLSLGDLGLLKPATVLYQAKS-------------------------------------------------------------FSESEIKKLLPGAIAFTQKAMQQSNYYLWGGTVGPNYDCSGLMQAAFVSVGIWLPRDAYQQEAFTQAIT----IDELAPGDLVFFGT------PVKATHVGLYLGDGCYIHSSGKIGIDILSEQGDVVSRSYYQQLRGAGRVVKSYKPQR.............. 234
5 -59.9002evr_A mol:protein length:246 COG0791: Cell wall-associated hydrolases (inv  ali model follow..  20  1...................................................................................MGSDKIMVRLSEAEVQ-NPKLGEYQCLADLNLFDSPECT-RLATQSASGRHLWVTSNHQNAVEVYLEDDYPGWLSLSDFDSLQPATSEIKKLLAEVIAFTQKAQSNYYLWGGTVGPNYDCSGLMQAAFASVGIWLPRDAYQQEGFTQPIT----IAELVAGDLVFFGTS------QKATHVGLYLADGYYIHSSGKIGIDILSEQGDAVSLSYYQQLRGAGRVFKSYEPQ............... 238
6 -59.7003m1u_A mol:protein length:434 Putative gamma-D-glutamyl-L-diamino acid endo  ali model follow..  13  124........................SALREVPTLRPMFTAPTRAGQGYPFDMFQRTAVWMGTPVFVGHATAWLYVET-AFAAGWMPAADVARVDDAFMTRYESGSLAAILRDDTSLNGADG---THLATAHIGTVLPLSGASQVGRTVLVPVRAPE-VVPVLLTSGEAAQKPVPLTPGNMAELGNRMMGQPYGWGGLYE-DRDCSSTLRDLFTPFGLWLPRNSASQAKAGRYVD----IAKLDADDKEARIVAEGVPFMTLLGHITLYLGLAAMFHNMWGIRTHRGG---------VEGRYVLGRAVVTSTRPGLDVPGNDNADGLLGR 422
7 -51.8002k1g_A mol:protein length:135 Lipoprotein spr  ali model follow..  28  3............................................................................................................................................................................VDVKSRIMDQYADWKGVRYRLGGSTKKGIDCSGFVQRTFRQFGLELPRSTYEQQEMGKSVS----RSNLRTGDLVLFRAG------STGRHVGIYIGNNQFVHASTSSGVI----ISSMNEPYWKKRYNEARRVLSRS.................. 127
8 -50.5003i86_A mol:protein length:141 Putative uncharacterized protein  ali model follow..  30  2.....................................................................................................................................................................STGSVYGRQAIEYVIKRMGSQMGVPYSWGGGSLTGFDCSGLMRYGFAGVGVLIPRFSGDQYNAGRHIP----QDQARRGDLIFYGPGG-------SQHVTMYLGNGQMLEASGSAGKVTVSPVRKPG-------TPFLTRIIE.................... 140
9 -50.3003pbi_A mol:protein length:214 INVASION PROTEIN  ali model follow..  31  78........................................................................................................................................................................RANARQAVEYVIRRAGSQMGVPYSWGGGSLQGFDCSGLVRYAFAGVGVLIPRFSGDQYNAGRHVP----PAEAKRGDLIFYGPGG-------GQHVTLYLGNGQMLEASGSAGKVTVSPVRKAG-------TPFVTRIIE.................... 213
10 -50.3003gt2_A mol:protein length:142 Putative uncharacterized protein  ali model follow..  23  6.....................................................................................................................................................................GVRAMDYQQATDVVIARGLSQRGVPFSWAGGGIVGFDASGLMQYAYAGAGIKLPRSSGAMYRVGQKILP----QQARKGDLIFYGPEG-------TQSVAMYLGNNQMLEVGDVVQVSPVRTAGMAP---------YMVRVLGT................... 142
11 -47.6003ne0_A mol:protein length:214 Resuscitation promoting factor Interacting Pr  ali model follow..  27  78........................................................................................................................................................................RVYGRQASEYVIRRGMSQIGVPYSWGGGNAAGFDCSGLVLYSFAGVGIKLPHYSGSQYNLGRKIP----SSQMRRGDVIFYGPNG-------SQHVTIYLGNGQMLEAPDVGLKVRVAPVRTAG-------TPYVVRYIE.................... 213
12 -47.4003s0q_A mol:protein length:215 INVASION PROTEIN  ali model follow..  27  79........................................................................................................................................................................RVYGRQASEYVIRRGMSQIGVPYSWGGGNAAGFDASGLVLYSFAGVGIKLPHYSGSQYNLGRKIP----SSQMRRGDVIFYGPNG-------SQHVTIYLGNGQMLEAPDVGLKVRVAPVRTAG-------TPYVVRYIE.................... 214
13 -44.1004hpe_A mol:protein length:308 Putative cell wall hydrolase Tn916-like,CTn1-  ali model follow..  27  180........................................................................................................................................................................PQVSGELAQKVMNEALKYQGWKYVYGGSNPTSFDCSGLTQWCYGKAGISLPRTAQAQYDATQHLP----LSQAKAGDLVFFHS--TYNAGSYVTHVGIYVGNNQMYHAGDPIGYADLS------SSYWQQHLIGAGRVKQ.................... 308
14 -43.3004fdy_A mol:protein length:313 Similar to lipoprotein, NLP/P60 family  ali model follow..  28  182......................................................................................................................................................................SPTEFDDETVQVIMDEALKYEGFPYVFGGASPTSFDCSGLIQWVYDKAGISLPRVAQDQYDATQEISM----EEAQAGDLIFFHS--TYNAGTYVTHVAIYLEGNRFYHAGDPIGYGDLS------SRYWQDHLIGARRVIHN................... 313
15 -21.2002p1g_A mol:protein length:249 Putative xylanase  ali model follow..  11  12...................................................................................NGLGFVDTPYKAGTLEVDDTEDLIINCDEVDCTTFVEYALAMALCPQQGDEMQEGDFARNLQRIRYRDGKDGYTSRLHYISLEDVTAAYSPFKQKLSLSYMSTHPELYKSLKNSPENVAQMAKYEK-----ALSGKEVHYLPKDKLEPDG----LPWIKNGDIIALTTNTPG----DVSHMGIAIGQLHLLHASSKEGKVVVGKTAL---SQMLKDRKSLTGIR..................... 235
16 -20.5004h4j_A mol:protein length:240 hypothetical protein  ali model follow..  11  19..................................................................................YVAHTLEADGPEELVINCDEVDCTTLVEYVLAETLTPKLADGDISESAFADNLQKIRYRDG--KIDGYTSRLHYIAGVRNGFLQDVTGAMSPDTERLSISYMSSHPQLYKQLANSPENVAKMKKIEQSLSGKEVHLPKAKLPADG----------LPWIKDGDIIAITTNTPG----DVAHMGIAFNKLLLVHASSTDKKVVVSKVPL---SQMLKDNNKWTGIR..................... 234
17 -16.1002kt8_A mol:protein length:76 Probable surface protein  ali model follow..  18  1............................AEKTGIVNVSSSLNVREGASTSSKVIGSLSGNTKVTIVGEGAFYKIEY-KGSHGYVAKEYIKDIKDEVLE...................................................................................................................................................................................................................................... 70
18 -16.0004EYZ Entity 1(prereleased)  ali follow..  16  44.........................................................................................................................................................................................YKGTPYIDWVFASSGLNXMGFVWHAIAKGLSVESDYYNLHYYEFPTKEEMLSSGVLQKGDIIWCVDGSVGLGMAGLRHIGIYTGNDSWWQSGDGDLVNVGTDVCPIYGAAAKNTYVVLP........................ 241
19 -15.6002krs_A mol:protein length:74 Probable enterotoxin  ali model follow..  23  5..................................VKVNSALNMRSGPGSNYGVIGTLRNNDKVEIIKEDGWYEIRF-NGKVGYASKSYITIVNEGSLE...................................................................................................................................................................................................................................... 68
20 -15.5002lkt_A mol:protein length:125 Retinoic acid receptor responder protein 3  ali model follow..  20  1.........................................................................................................................................................................................................................................MASPHQEPKPGDLIEI-------FRLGYEHWALYIGDGYVIHLAPPSEYPGAGSS........................................ 48
21 -15.2002kq8_A mol:protein length:70 Cell wall hydrolase  ali model follow..  18  5.................................YYINASALNVRSGEGTNYRIIGALPQGQKVQVISNSGWSKIN-YNGQTGYIGTRYLSKLE........................................................................................................................................................................................................................................... 64
22 -14.8004dot_A mol:protein length:140 Group XVI phospholipase A2  ali model follow..  16  1.........................................................................................................................................................................................................................................MRAPIPEPKPGDLIEIF-------RPFYRHWAIYVGDGYVVHLAPPSEVAGAGAAS....................................... 49
23 -14.7004fa0_A mol:protein length:137 Group XVI phospholipase A1/A2  ali model follow..  16  3........................................................................................................................................................................................................................................AMRAPIPEPKPGDLIEIF-------RPFYRHWAIYVGDGYVVHLAPPSEVAGAGAAS....................................... 52
24 -14.6004dpz_X mol:protein length:137 HRAS-like suppressor 2  ali model follow..  22  1.........................................................................................................................................................................................................................................MALARPRPRLGDLIEIS-------RFGYAHWAIYVGDGYVVHLAPASEIAGAGAAS....................................... 49
25 -14.4002im9_A mol:protein length:333 Hypothetical protein  ali model follow..  18  43....................................................................................................................................................................HTLNTMPNTSMADRISQISAYFKGTKYLGEGPNADGFDCDTYVNTVLSLAGLLIPFTALFSENKPNLHL----FSQIPNGAVIEIIRPNWDLRQQDISHLGFAINELFFRQASSQYGKVVDVSLIDYLDKARSSPTIKGINIQVVLPEKPVSNGCQ........ 328
26 -13.8002kyb_A mol:protein length:60 Mannosyl-glycoprotein endo-beta-N-acetylgluco  ali model follow..  20  6..................................VNVSSSLNVRSSASTSSKVIGSLSGNTKVTIVGEGAFYKIE-YKGSHGYVAKEYI............................................................................................................................................................................................................................................... 60
27 -13.3002if6_A mol:protein length:186 Hypothetical protein yiiX  ali model follow..  14  1............................................................................................................................................................................................................................................SLWQPQTGDIIFQISRSSQSKHSDYSHTGMLVMRNKKPYVFEAVGPVKYTPLKQWIAHGEKGKYV-VRRVEGGLSVEQQQKLAQ........ 89
28 -12.8001ng2_A mol:protein length:193 Neutrophil cytosolic factor 1  ali model follow..  14  21.............................................EKTSGSEM--ALSTGDVVEVVEKSGWWFCQM-KAKRGWIPASFLEPLDSPDETEDPEPNYAGEPYVAIKAYTAVEGDE---VSLLEGEAVEVIHKLDGWWVIRK-DDVTGYFPSMYLQKSGQDVSQAQRQIKRGAPPRRSSIRNAHSIHQRSRKRLS.............................................................................................................................. 173
29 -12.5001uec_A mol:protein length:193 Neutrophil cytosol factor 1  ali model follow..  14  21.............................................EKTSGSEM--ALSTGDVVEVVEKSGWWFCQM-KAKRGWIPASFLEPLDSPDETEDPEPNYAGEPYVAIKAYTAVEGDE---VSLLEGEAVEVIHKLDGWWVIRK-DDVTGYFPSMYLQKSGQDVSQAQRQIKR...................................................................................................................................................... 149
30 -11.3001wlp_B mol:protein length:138 Neutrophil cytosol factor 1  ali model follow..  14  1............................GSDITGPIILQTYRAIADYEKTSGSEMALSTGDVVEVVEKSGWWFCQM-KAKRGWIPASFLEPLDSPDETEDPEPNYAGEPYVAIKAYTAVEGDE---VSLLEGEAVEVIHKLDGWWVIRK-DDVTGYFPSMYLQKSGQ................................................................................................................................................................. 137
31 -10.5003kw0_A mol:protein length:214 Cysteine peptidase  ali model follow..  10  5...................................................................................................................................................................................................................KIENLYFQGMGTDKFNNIKIDKYENLINVLKTGDIFLCSGNYLVSKESMFSHTGIIVKWGEIMESVED................................................. 81
32 -9.7403nhn_A mol:protein length:193 Tyrosine-protein kinase HCK  ali model follow..  13  27...............................................................................................................................SFQKGDQMVVLEESGEWKARSLATRKEGYIPSNYVARVDSLETE------------------EWFFKGISRK--DAERQLLAPGNMLGSFMIRDSETT-----------------KGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQK.............. 177
33 -9.5302l3s_A mol:protein length:163 Autoinhibited Crk protein  ali model follow..  10  1...................................VEYVRALFDFNGNDDEDL--PFKKGDILKIRDKEQWWNAEDMDGKRGMIPVPYVEKCRPSSASVSTLTGGNQDSSHRVIQKRVPNAYDKTALALEVGELVKVTKINMSGQWEGECNGKRGHFPFTHVRLLDQ................................................................................................................................................................. 163
FFAS is supported by the NIH grant R01-GM087218-01
4 7 3 3 7   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
 Locations of visitors to this page
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Doukhanina EV, Chen S, van der Zalm E, Godzik A, Reed J, Dickman MB. Identification and functional characterization of the BAG protein family inArabidopsis thaliana. Biol Chem. 2006 Jul 7;281(27):18793-801. Epub 2006 Apr 24.

                                                                                                                                                                                                   

Contact Webmaster JCSG Menu